Description

Neuronox 100: Proven Bioequivalence and Benchmark Quality

Neuronox 100 is a premium botulinum toxin type A developed by Medytox, the leading South Korean biopharmaceutical company. Featuring a classic molecular weight of 900 kDa, this product is a widely recognized clinical equivalent (biosimilar) to the original American Botox. It guarantees practitioners an absolutely identical diffusion profile, potency, and a strict 1:1 dosing ratio. This allows specialists to seamlessly apply their standard protocols, achieving benchmark muscle relaxation results while optimizing procedure costs.

Key Benefits Neuronox 100:

Strict Bioequivalence: Dilution and dosing protocols exactly match (1:1) the standards used for original Botox, eliminating the need for retraining or dose adjustments.

Precision and Predictability: The large molecule (900 kDa) ensures strict localization of the toxin at the injection site, minimizing the risk of unwanted diffusion and ptosis.

Global Trust: Backed by an extensive evidence base, Neuronox has been successfully used for over 15 years and is approved in more than 50 countries worldwide.

Lasting Results: Delivers a reliable neuromuscular block with clinical efficacy lasting up to 5-6 months.

Indications:

Correction of dynamic wrinkles in the upper third of the face (glabella, forehead, crow’s feet).

Correction of masseter muscle hypertonicity (bruxism treatment, lower face slimming).

Smoothing of platysmal bands (neck rejuvenation).

Treatment of localized hyperhidrosis.

Specifications:

Active Ingredient: Botulinum Toxin Type A (100 Units).

Form: Lyophilized powder (1 vial).

Manufacturer: Medytox (South Korea).